General Information
BounceWatch is an independent company data service, not affiliated with Microbiotica . To contact Microbiotica , visit microbiotica.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Microbiotica compare?
A PDF of Microbiotica and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Microbiotica soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Microbiotica on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United Kingdom Market
Biotechnology
About Microbiotica
Business keywords: Microbiome, Biotech, Research, Clinical Trials, Cancer, Oncology, Immuno-oncology, IBD, Microbiology, Therapeutics, Cell Biology, Bioinformatics
Services & Products
Target Customers
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | Undisclosed | 6 | 27 Aug 2024 | |
| Series B | £50.00M | 6 | 07 Feb 2022 | |
| Venture Round | £4.00M | 1 | 24 Oct 2018 | |
| Seed Round | £8.00M | 2 | 19 Dec 2016 |
Latest News
View AllMicrobiotica Alternatives & Competitors
View All AlternativesMerus was acquired by Genmab. To see what’s new, visit Genmab.
We are a synthetic biology company developing a platform to industrialize and scale the microbiome.
FAQ About Microbiotica
Source: BounceWatch company record for Microbiotica , https://www.bouncewatch.com/company/microbiotica, updated 24 February 2025. When citing, please name BounceWatch and link this page.